Has Shine Lawyers left the ASX in the dark over its Johnson & Johnson pelvic mesh fee-fest?
Is Shine Justice being straight with the ASX over its profits from the $300m pelvic mesh class action against Johnson & Johnson? Michael West investigates an accounting and disclosure mystery.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed